The Journal of Organic Chemistry
Article
oxazin-3(4H)-one 3a (39 mg, 89%) as a white solid. Melting Point:
126−128 °C. H NMR (400 MHz, CDCl3) δ 8.84 (bs, 1H), 7.03−
23.61*, 23.06, 23.05*, 19.15, 19.14*, 14.2, 11.2, 11.0*. (The starred
peaks in 13C NMR shows the presence of diastereoisomer). FTIR
(KBr) 3486, 2929, 1693, 1503, 1399, 1242, 1099 cm−1. HRMS (ESI-
TOF) m/z (M + Na)+ Calcd for C17H25NO3Na 314.1732, found
314.1733.
1
6.96 (m, 3H), 6.90−6.85 (m, 1H), 3.74−3.62 (m, 2H), 1.78 (s, 3H),
1.06 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 164.7,
141.7, 126.6, 124.1, 122.9, 117.4, 115.7, 99.3, 58.3, 19.6, 15.3. FTIR
(KBr) 3452, 1712, 1506, 1398, 1246, 1172, 1108, 1046 cm−1. HRMS
(ESI-TOF) m/z [M + Na]+ Calcd for C11H13NO3Na 230.0793, found
230.0795.
2-Methyl-2-(octyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one (3g).
Prepared according to general procedure (A), using 3-(tert-
butylperoxy)-3-methylindolin-2-one (50 mg, 0.21 mmol) to afford
2-methyl-2-(octyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one 3g (40
mg, 65%) as a white solid. Melting Point: 88−90 °C. 1H NMR
(400 MHz, CDCl3) δ 9.35 (bs, 1H), 7.02−6.95 (m, 3H), 6.93−6.88
(m, 1H), 3.64−3.54 (m, 2H), 1.78 (s, 3H), 1.45−1.36 (m, 2H),
1.29−1.01 (m, 10H), 0.85 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (100
MHz, CDCl3) δ 165.0, 141.7, 126.7, 124.0, 122.8, 117.4, 115.8, 99.1,
62.4, 31.9, 29.6, 29.3, 29.3, 26.0, 22.8, 19.4, 14.2. FTIR (KBr) 3400,
3168, 2326, 1717, 1620, 1502, 1409, 1102 cm−1. HRMS (ESI-TOF)
m/z (M + Na)+ Calcd for C17H25NO3Na 314.1732, found 314.1735.
2-(2-Ethoxyethoxy)-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one
(3h). Prepared according to general procedure (A), using 3-(tert-
butylperoxy)-3-methylindolin-2-one (50 mg, 0.21 mmol) to afford 2-
(2-ethoxyethoxy)-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one 3h
(37.5 mg, 70%) as a light yellow semisolid. Melting Point: 65−67
2-Methoxy-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one (3b).
Prepared according to general procedure (A), using 3-(tert-
butylperoxy)-3-methylindolin-2-one (50 mg, 0.21 mmol) to afford
2-methoxy-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one 3b (33.5
1
mg, 82%) as a white solid. Melting Point: 110−112 °C. H NMR
(400 MHz, CDCl3) δ 9.28 (bs, 1H), 7.06−6.97 (m, 3H), 6.93−6.89
(m, 1H), 3.35 (s, 3H), 1.78 (s, 3H). 13C{1H} NMR (100 MHz,
CDCl3) δ 164.7, 141.5, 126.5, 124.2, 123.0, 117.4, 115.9, 99.3, 49.9,
18.9. FTIR (KBr) 3533, 1699, 1506, 1245, 1171, 1109 cm−1. HRMS
(ESI-TOF) m/z (M + Na)+ Calcd for C10H11NO3Na 216.0637,
found 216.0640.
2-Methyl-2-propoxy-2H-benzo[b][1,4]oxazin-3(4H)-one (3c).
Prepared according to general procedure (A), using 3-(tert-
butylperoxy)-3-methylindolin-2-one (50 mg, 0.21 mmol) to afford
2-methyl-2-propoxy-2H-benzo[b][1,4]oxazin-3(4H)-one 3c (33 mg,
1
°C. H NMR (400 MHz, CDCl3) δ 9.42 (bs, 1H), 7.03−6.95 (m,
1
3H), 6.93−6.87 (m, 1H), 3.81−3.71 (m, 2H), 3.43 (t, J = 5.3 Hz,
2H), 3.39−3.28 (m, 2H), 1.79 (s, 3H), 1.04 (t, J = 7.0 Hz, 3H).
13C{1H} NMR (100 MHz, CDCl3) δ 164.6, 141.5, 126.6, 124.1,
122.9, 117.4, 115.9, 99.1, 69.1, 66.7, 62.0, 19.5, 15.2. FTIR (KBr)
3427, 1713, 1609, 1504, 1399, 1259, 1124, 1063 cm−1. HRMS (ESI-
TOF) m/z (M + Na)+ Calcd for C13H17NO4Na 274.1055, found
274.1058.
70%) as a white solid. Melting Point: 115−117 °C. H NMR (400
MHz, CDCl3) δ 9.12 (s, 1H), 7.03−6.96 (m, 3H), 6.92−6.87 (m,
1H), 3.56 (qt, J = 8.8, 6.5 Hz, 2H), 1.78 (s, 3H), 1.48−1.39 (m, 2H),
0.69 (t, J = 7.4 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 164.8,
141.7, 126.7 124.0, 122.8, 117.4, 115.7, 99.1, 64.0, 22.9, 19.4, 10.5.
FTIR (KBr) 3078, 2925, 1714, 1614, 1505, 1398, 1107 cm−1. HRMS
(ESI-TOF) m/z (M + H)+ Calcd for C12H15NO3 222.1130, found
222.1121.
2-Ethoxy-2-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one (3i). Pre-
pared according to general procedure (A), using 3-(tert-butylperoxy)-
3-phenylindolin-2-one (50 mg, 0.17 mmol) to afford 2-ethoxy-2-
phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one 3i (33 mg, 73%) as a
white solid. Melting Point: 187−188 °C. 1H NMR (400 MHz,
CDCl3) δ 9.00 (bs, 1H), 7.75−7.68 (m, 2H), 7.47−7.39 (m, 3H),
7.16−7.12 (m, 1H), 7.08−6.99 (m, 2H), 6.87−6.84 (m, 1H), 3.61−
3.47 (m, 2H), 1.08 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (100 MHz,
CDCl3) δ 163.7, 141.5, 135.1, 129.4, 128.2, 127.9, 126.6, 124.2, 123.1,
117.5, 115.8, 100.6, 59.8, 15.2. FTIR (KBr) 3369, 2847, 1723, 1630,
1502, 1267 cm−1. HRMS (ESI-TOF) m/z (M + Na)+ Calcd for
C16H15NO3Na 292.0950, found 292.0950.
2-Butoxy-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one (3d). Pre-
pared according to general procedure (A), using 3-(tert-butylperoxy)-
3-methylindolin-2-one (50 mg, 0.21 mmol) to afford 2-butoxy-2-
methyl-2H-benzo[b][1,4]oxazin-3(4H)-one 3d (36.5 mg, 73%) as a
white solid. Melting Point: 98−100 °C. 1H NMR (400 MHz, CDCl3)
δ 8.98 (bs, 1H), 7.03−6.96 (m, 3H), 6.91−6.85 (m, 1H), 3.65−3.54
(m, 2H), 1.78 (s, 3H), 1.44−1.35 (m, 2H), 1.18−1.07 (m, 2H), 0.76
(t, J = 7.4 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 164.7,
141.7, 126.7, 124.0, 122.8, 117.5, 115.6, 99.1, 62.2, 31.6, 19.4, 19.1,
13.8. FTIR (KBr) 3407, 3224, 2917, 1714, 1619, 1505, 1398, 1105
cm−1. HRMS (ESI-TOF) m/z (M + Na)+ Calcd for C13H17NO3Na
258.1106, found 258.1110.
2-Methyl-2-(pentyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one (3e).
Prepared according to general procedure (A), using 3-(tert-
butylperoxy)-3-methylindolin-2-one (50 mg, 0.21 mmol) to afford
2-methyl-2-(pentyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one 3e (38
mg, 72%) as a white solid. Melting Point: 91−92 °C. 1H NMR
(400 MHz, CDCl3) δ 9.50 (bs, 1H), 7.02−6.95 (m, 3H), 6.94−6.89
(m, 1H), 3.64−3.54 (m, 2H), 1.78 (s, 3H), 1.45−1.37 (m, 2H), 1.16
(qd, J = 7.6, 1.4 Hz, 2H), 1.10−1.01 (m, 2H), 0.76 (t, J = 7.2 Hz,
3H). 13C{1H} NMR (100 MHz, CDCl3) δ 165.1, 141.7, 126.7, 124.0,
122.8, 117.4, 115.8, 99.0, 62.4, 29.3, 28.1, 22.4, 19.5, 14.0. FTIR
(KBr) 3452, 2938, 2583, 2363, 1714, 1614, 1504, 1396, 1246, 1102,
cm−1. HRMS (ESI-TOF) m/z (M + Na)+ Calcd for C14H19NO3Na
272.1263, found 272.1268.
2-Methoxy-2-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one (3j).
Prepared according to general procedure (A), using 3-(tert-
butylperoxy)-3-phenylindolin-2-one (50 mg, 0.17 mmol) to afford
2-methoxy-2-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one 3j (38.5 mg,
1
90%) as a white solid. Melting Point: 178−180 °C. H NMR (400
MHz, CDCl3) δ 8.6 (bs, 1H), 7.73−7.68 (m, 2H), 7.48−7.40 (m,
3H), 7.17 (d, J = 7.3 Hz, 1H), 7.12−7.00 (m, 2H), 6.88−6.83 (m,
1H), 3.25 (s, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 163.3, 141.3,
134.2, 129.5, 128.3, 128.0, 126.6, 124.3, 123.3, 117.7, 115.7, 100.6,
51.1. FTIR (KBr) 3420, 3216, 2990, 2856, 1666, 1623, 1506, 1267,
1030 cm−1. HRMS (ESI-TOF) m/z (M + Na)+ Calcd for
C15H13NO3Na 278.0793, found 278.0794.
2-Butoxy-2-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one (3k). Pre-
pared according to general procedure (A), using 3-(tert-butylperoxy)-
3-phenylindolin-2-one (50 mg, 0.17 mmol) to afford 2-butoxy-2-
phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one 3k (40.5 mg, 81%) as a
white solid. Melting Point: 133−135 °C. 1H NMR (400 MHz,
CDCl3) δ 8.43 (bs, 1H), 7.73−7.69 (m, 2H), 7.47−7.41 (m, 3H),
7.15 (dd, J = 7.2, 2.1 Hz, 1H), 7.08−6.99 (m, 2H), 6.86−6.83 (m,
1H), 3.51−3.38 (m, 2H), 1.46−1.38 (m, 2H), 1.22−1.11 (m, 2H),
0.76 (t, J = 7.4 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 163.4,
141.5, 134.9, 129.4, 128.2, 128.0, 126.6, 124.1, 123.1, 117.7, 115.5,
100.4, 63.5, 31.6, 19.2, 13.8. FTIR (KBr) 3425, 3301, 3152, 2959,
2930, 1705, 1622, 1506, 1384, 1252 cm−1. HRMS (ESI-TOF) m/z
(M + Na)+ Calcd for C18H19NO3Na 320.1263, found 320.1262.
2-(Cyclohexyloxy)-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one
(3l). Prepared according to general procedure (A), using 3-(tert-
butylperoxy)-3-methylindolin-2-one (50 mg, 0.21 mmol) to afford 2-
2-((2-Ethylhexyl)oxy)-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-
one (3f). Prepared according to general procedure (A), using 3-(tert-
butylperoxy)-3-methylindolin-2-one (50 mg, 0.21 mmol) to afford 2-
((2-ethylhexyl)oxy)-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one 3f
(28 mg, 45%) as a white solid. The obtained compound is
diastereoisomer and distinguished by 13C NMR. Melting Point:
67−69 °C. 1H NMR (400 MHz, CDCl3) δ 8.30 (bs, 1H), 7.03−6.96
(m, 3H), 6.88−6.81 (m, 1H), 3.51−3.42 (m, 2H), 1.78 (s, 3H),
1.34−1.28 (m, 1H), 1.17−1.00 (m, 8H), 0.83−0.76 (m, 3H), 0.73−
0.67 (m, 3H). (The merging of two triplets in between the range of
1
0.83−0.76 and 0.73−0.67 ppm in H NMR shows the presence of
diastereoisomer. By NMR the dr ratio is ∼50:50%). 13C{1H} NMR
(100 MHz, CDCl3) δ 164.3, 141.7, 126.8, 124.0, 122.8, 117.6, 115.4,
99.0, 64.6, 64.3*, 39.50, 39.48*, 30.40, 30.36*, 29.1, 28.9*, 23.65,
3380
J. Org. Chem. 2020, 85, 3374−3382